Molecular Insight Pharmaceuticals is buying a commercial-scale
radiopharmaceutical manufacturing facility in Texas for $3m as it
moves towards increasing its manufacturing in the increasingly
profitable pharmaceutical area.
The latest research included in the proceedings of the annual
meeting of the European Society of Cardiology, (ESC) means that
heart treatments and management therapies feature strongly in
DrugResearcher's round-up of the 5-day...
A new study, which uses a new method in identifying the specific
gene involved in high cholesterol has been hailed as, "a landmark
publication." The study also describes the potential to use this
approach in forming a treatment...
There is no doubt that the introduction of stents, and latterly
those that deliver pharmacological agents, has revolutionised the
treatment of coronary artery disease over the last 10 years and all
but consigned heart surgery to second-line...
A naturally occurring protein, which promotes the ability to repair
heart muscle after a myocardial infarction, significantly reducing
cardiac damage, may have drug applications as a wound healing
treatment for the heart.